Integrated computational approach for in silico design of new purinyl pyridine derivatives as B-Raf kinase inhibitors

References

• Vivek A, Kar Mahapatra D, Bharti SK. PI3K/akt/mTOR and ras/raf/MEK/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives. ejmech. 2016;10:314–341.
   Google Scholar
• Yu-Shun Y, Zhang F, Tang D-J, et al. Modification, biological evaluation and 3D QSAR studies of novel 2-(1,3-Diaryl- 4,5-Dihydro-1H-Pyrazol-5- yl) phenol derivatives as inhibitors of B-Raf kinase. PLoS One. 2014;9(5):e95702.
   PubMed Web of Science ®Google Scholar
• Abdullahi BU, Uzairu A, Shallangwa GA, et al. In silico evaluation of some 4-(quinolin-2- yl) pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions. Futur J Pharm Sci. 2020;61(6):1–10.
   Google Scholar
• Yong Ai S-TW, Tang C, et al. 3D-QSAR and docking studies on pyridopyrazinones as BRAF inhibitors. Med Chem Res. 2011;20:1298–1317.
   Web of Science ®Google Scholar
• Lu Wang QZ, Zhu G. y, et al. Design, synthesis and evaluation of derivatives based on pyrimidine scaffold as potent Pan-Raf inhibitors to overcome resistance. Ejmech. 2017;15:3455–3465.
   Google Scholar
• Asati V. Debarshi kar mahapatra, sanjay kumar bharti. K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives. Ejmech. 2017;125:299–314.
   Google Scholar
• Knight T, Irving JAE. Ras/raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukaemia and its therapeutic targeting. Front. Oncol. 2014;160(4):1–10.
   Google Scholar
• El-Nassan HB. Recent progress in the identification of BRAF inhibitors as anti-cancer agents. Ejmech. 2014;72:170–205.
   Google Scholar
• Karouta Z. Evripidis gavathiotis, poulikos I. Poulikakos. New perspectives for targeting RAF kinase in human cancer. Nat Rev Cancer. 2017;17(11):679–691.
   Google Scholar
• Wang L, Zhu G. y, Zhang Q, et al. Rational design, synthesis, and biological evaluation of Pan-Raf inhibitors to overcome resistance. Ejmech. 2017;15:3455–3465.
   Google Scholar
• Saikiran Reddy P, Kanth Sivan S, Manga V. Discovery and design of new PI3K inhibitors through pharmacophore-based virtual screening, molecular docking, and binding free energy analysis. Struct Chem. 2018;29:1753–1766.
   Web of Science ®Google Scholar
• Yang W, Chen Y, Zhou X, et al. Design, synthesis and biological evaluation of bis-aryl ureas and amides based on 2-amino-3-purinylpyridine scaffold as DFG-out B-Raf kinase inhibitors. ejmech. 2015;89:581–596.
   Google Scholar
• Schrodinger LLC Glide, version 5.6 New York, NY. 2010.
   Google Scholar
• Dixon SL, Smondyrev AM, Knoll EH, et al. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des. 2006;20(10-11):647–671.
   PubMed Web of Science ®Google Scholar
• Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47(7):1739–1749.
   PubMed Web of Science ®Google Scholar
• Saikiran RP, Kanth Sivan S, Manga V. Molecular dynamics and MM/GBSA integrated protocol probing the correlation between biological activities and binding free energies of HIV-1 TAR RNA inhibitors. J Biomol Struct Dyn. 2018; 36:486–503.
   PubMed Web of Science ®Google Scholar
• Li J, Abel R, Zhu K, et al. The VSGB 2.0 model: a next generation energy model for high resolution protein structure modelling. Proteins. 2011;79(10):2794–2812.
   PubMed Web of Science ®Google Scholar
• Still WC, Tempczyk A, Hawley RC, et al. Semi analytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc. 1990;112(16):6127–6129.
   Web of Science ®Google Scholar
• Tanusree D, Swapan M, Arunasree M, et al. Identification of potent histone deacetylase 8 inhibitors using pharmacophore-based virtual screening, three-dimensional quantitative structure–activity relationship, and docking study. Res Reports Medic Chem. 2015;5:21–39.
   Google Scholar
• Kaur P, Sharma V, Kumar V. Pharmacophore modelling and 3D-QSAR studies on N3- Phenyl pyrazinones as corticotropin-Releasing factor 1 receptor antagonists. 2012;2012:1–13.
   Google Scholar
• Chauhan N, Vidyarthi AS, Poddar R. Pharmacophore modeling and 3D-QSAR study of acridine derivatives for the development of better antileishmanial agents. IJIRSET. 2013;2(11):6254–6261.
   Google Scholar
• Tsai J, Lee JT, Wang W, et al. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc Natl Acad Sci USA. 2008;105(8):3041–3046.
   PubMed Web of Science ®Google Scholar
• Santos CB, Macedo WJC. Molecular modelling: origin, fundamental concepts & applications using structure- activity relationship and quantitative structure activity relationship. Rev Theoretical Sci. 2014;2:1–25.
   Google Scholar
• Vangala R, Sivan SK, Peddi SR, et al. Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120 J Comput Aided Mol Des. 2020;34(1):39–54.
   PubMed Web of Science ®Google Scholar
• Itteboina R, Ballu Sree Kanth Sivan S, Manga V. Molecular docking, 3D QSAR and dynamics simulation studies of imidazo-pyrrolopyridines as janus kinase 1 (jak 1) inhibitors. J Compbiolchem. 2016;64:33–46.
   Google Scholar
• Bathini R, Sivan S. K, Fatima S, et al. Molecular docking, MM/GBSA and 3D-QSAR studies on EGFR inhibitors. J Chem Sci. 2016;128(7):1163–1173.
   Web of Science ®Google Scholar
• Chitta A, Sivan SK, Manga V. 3D QSAR based design of novel oxindole derivative as 5HT7 inhibitors. J Recept Signal Transduct Res. 2014;34(3):185–194.
   PubMed Web of Science ®Google Scholar
• Tanwar O, Marella A, Shrivastava S, et al. Pharmacophore model generation and 3D-QSAR analysis of N-acyl and N-aroylpyrazolines for enzymatic and cellular B-Raf kinase inhibition. Med Chem Res. 2013;22(5):2174–2187.
   Web of Science ®Google Scholar
• Vani T, Balabadra M, Vijjulatha M. In silico design: Those accentuate assembly of HIV-1 capsid. Nov Appro Drug Des Dev. 2017;2(5):001–0010.
   Google Scholar
• Rama krishna munnaluri and vijjulatha manga. in silico quest guided by Physico-Chemical descriptors of bedaquiline for new scaffolds with potential inhibitory capacity against homology model of Mycobacterium F1F0 ATP synthase. Asian J Chem. 2018; 30:904–912.
   Google Scholar
• Kumar TVA, Alias Anand A, Loganathan C, et al. Design, 3D QSAR modelling and docking of TGF-β type I inhibitors to target cancer. J Compbiol Chem. 2018;76:232–234.
   Google Scholar